Dear All
For those who hadn't heard before this, Australia's National Blood Authority has now formally approved access to subcutaneous immunoglobulin, for four indications:
- Primary immunodeficiency diseases with antibody deficiency
- Specific antibody deficiency
- Acquired hypogammaglobulinaemia secondary to haematological malignancies (chronic lymphocytic leukaemia, multiple myeloma, non-Hodgkin lymphoma and other relevant malignancies, and post-haemopoietic stem cell transplantation)
- Secondary hypogammaglobulinaemia (including iatrogenic immunodeficiency)
For further information ,visit NBA Website
